August 17, 2010
Terumo and Asahi Intecc to Launch Guidewire Tie-up
Terumo Corporation
Asahi Intecc Co., Ltd.
Terumo Corporation (President: Yutaro Shintaku, “Terumo”) and Asahi Intecc Co., Ltd. (President: Masahiko Miyata, “Asahi Intecc”) hereby announce that they have agreed to launch a cooperative medical guidewire development.
1. Details of the tie-up
- Terumo and Asahi Intecc will start joint development of guidewires to be used for catheterization diagnosing via the wrist artery (TRI). Jointly developed products will be manufactured by Asahi Intecc on an OEM basis.
TRI (Trans-Radial coronary Intervention) is a technique for diagnosing and treating arteries using a catheter inserted into the wrist artery.
Compared with the trans-femoral approach from the groin, TRI uses a smaller incision and results in less bleeding. Patients can get back on their feet soon after the procedure and may not be required to remain in hospital overnight. In recent years, TRI has become more widespread around the globe, partly because of the healthcare cost-cutting benefits it provides. - Mini guidewires to be included in diagnostic catheter kits will be manufactured by Asahi Intecc on an OEM basis and sold by Terumo.
Both Terumo and Asahi Intecc have previous involvement in the field of endovascular interventions. This tie-up will enable the two companies to combine their individual strengths in order to contribute to the spread of minimally invasive therapies and the improvement of healthcare quality, while at the same time further reinforcing their business interests.
2. Profiles of the two companies
- Terumo Corporation
| 1) Main business: |
Manufacturing and sale of medical products, equipment, and pharmaceutical products |
| 2) Head office: |
44-1, 2-chome, Hatagaya, Shibuya-ku, Tokyo, Japan |
| 3) Representative: |
Yutaro Shintaku, Representative Director & President |
| 4) Capital: |
38.7 billion yen |
| 5) Sales: |
316 billion yen (consolidated basis; for FYE 3/2010) |
|
|
- Asahi Intecc Co., Ltd.
| 1) Main business: |
Development, manufacture and sale of medical devices Development, manufacture and sale of ultrafine stainless wire rope, terminal processed wire rope, etc. |
| 2) Head office: |
1703 Wakita-cho, Moriyama-ku, Nagoya-shi, Aichi, Japan |
| 3) Representative: |
Masahiko Miyata, President |
| 4) Capital: |
4.1 billion yen |
| 5) Sales: |
15.3 billion yen (consolidated basis; for FYE 6/2010) |
3. Impact on performance
This tie-up is expected to have limited impact on the performance. The forecast for the current term will not be revised.
(Notice) Among the information that Terumo discloses, forecasts of financial performance on future projections contain potential risks and uncertainty since these are forecasts on projections made by Terumo based on limited information available at the moment of disclosure. Accordingly, it should be noted that actual results may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.
The market share information in this booklet is partly derived from our own independent research.
